Palisade Bio, Inc.
PALI
Price:
$1.805
Market Cap:
$4.99M
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.[Read more]
Industry
Biotechnology
IPO Date
2007-03-30
Stock Exchange
NASDAQ
Ticker
PALI
PE Ratio
[-0.14]
ROE
[-148.31%]
Current Ratio
[3.31]
Dividend Yield
[0%]
Enterprise Value
[-2690406.00]
Dividend History
The ROE as of December 2024 (TTM) for Palisade Bio, Inc. (PALI) is -148.31%
According to Palisade Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -148.31%. This represents a change of 282.52% compared to the average of -38.77% of the last 4 quarters.
Palisade Bio, Inc. (PALI) Historical ROE (quarterly & annually)
How has PALI ROE performed in the past?
The mean historical ROE of Palisade Bio, Inc. over the last ten years is -168.07%. The current -148.31% ROE has changed -11.76% with respect to the historical average. Over the past ten years (40 quarters), PALI's ROE was at its highest in in the March 2016 quarter at 3.90%. The ROE was at its lowest in in the June 2016 quarter at -460.56%.
Average
-168.07%
Median
-145.32%
Minimum
-420.83%
Maximum
63.67%
Palisade Bio, Inc. (PALI) ROE by Quarter and Year
Discovering the peaks and valleys of Palisade Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 229.53%
Maximum Annual ROE = 63.67%
Minimum Annual Increase = -681.59%
Minimum Annual ROE = -420.83%
| Year | ROE | Change |
|---|---|---|
| 2023 | -108.72% | 6.01% |
| 2022 | -102.56% | -72.30% |
| 2021 | -370.28% | -681.59% |
| 2020 | 63.67% | -139.08% |
| 2019 | -162.93% | 100.15% |
| 2018 | -81.40% | -55.75% |
| 2017 | -183.98% | -1.08% |
| 2016 | -185.99% | -55.80% |
| 2015 | -420.83% | 229.53% |
| 2014 | -127.71% | -45.79% |
Palisade Bio, Inc. (PALI) Average ROE
How has PALI ROE performed in the past?
The current ROE of Palisade Bio, Inc. (PALI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-193.86%
5-year avg
-136.17%
10-year avg
-168.07%
Palisade Bio, Inc. (PALI) ROE vs. Peers
How is PALI’s ROE compared to its peers?
Palisade Bio, Inc.’s ROE is greater than Zura Bio Limited (-39.61%), less than Altamira Therapeutics Ltd. (783.37%), greater than Immix Biopharma, Inc. (-102.10%), greater than Enveric Biosciences, Inc. (-201.01%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Virios Therapeutics, Inc. (-130.35%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than NovaBay Pharmaceuticals, Inc. (-1030.19%), greater than Unicycive Therapeutics, Inc. (-374.14%), less than Apexigen, Inc. (48.27%),
| Company | ROE | Market cap |
|---|---|---|
| -39.61% | $146.91M | |
| 783.37% | $1.13M | |
| -102.10% | $57.79M | |
| -201.01% | $3.28M | |
| 2.18% | $941.00 | |
| -130.35% | $206.50K | |
| -173.56% | $10.01K | |
| -25512.50% | $2.72M | |
| -134.57% | $2.33M | |
| -1030.19% | $2.50M | |
| -374.14% | $72.45M | |
| 48.27% | $9.57M |
Build a custom stock screener for Palisade Bio, Inc. (PALI) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palisade Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Palisade Bio, Inc. (PALI) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Palisade Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Palisade Bio, Inc.'s ROE?
How is the ROE calculated for Palisade Bio, Inc. (PALI)?
What is the highest ROE for Palisade Bio, Inc. (PALI)?
What is the 3-year average ROE for Palisade Bio, Inc. (PALI)?
What is the 5-year average ROE for Palisade Bio, Inc. (PALI)?
How does the current ROE for Palisade Bio, Inc. (PALI) compare to its historical average?